Understanding how branched chain amino acids affect diabetes and metabolism
Covalent regulation of branched chain amino acid metabolism
This study is looking at how certain amino acids, called branched chain amino acids (BCAAs), might affect the development of type 2 diabetes and insulin resistance, especially in people who are overweight, to find new ways to help manage diabetes through diet and treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11072074 on NIH RePORTER |
What this research studies
This research investigates the role of branched chain amino acids (BCAAs) in the development of type 2 diabetes and insulin resistance. It explores how high levels of BCAAs, often seen in individuals with obesity, may contribute to metabolic dysfunction. The study aims to identify the mechanisms by which BCAAs are metabolized and regulated in the body, potentially leading to new dietary or therapeutic strategies to improve insulin sensitivity and manage diabetes. By examining genetic variations and dietary impacts on BCAA levels, the research seeks to uncover novel approaches to diabetes treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults with obesity or insulin resistance, particularly those at risk for developing type 2 diabetes.
Not a fit: Patients who do not have issues related to obesity or insulin resistance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new dietary guidelines or therapies that help manage or prevent type 2 diabetes by targeting amino acid metabolism.
How similar studies have performed: Previous research has shown promising results in managing insulin sensitivity through dietary modifications related to amino acid metabolism, indicating that this approach has potential for success.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Finck, Brian N — Washington University
- Study coordinator: Finck, Brian N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.